Axon Therapy
Commercial- Indications
- Chronic painful diabetic neuropathy, Chronic intractable pain, Post operative pain, Post traumatic pain
Company intelligence / Profile preview
NeuraLace Medical
San Diego, California, United Statesneuralacemedical.squarespace.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Axon Therapy by NeuraLace Medical has received FDA clearance as the first non-invasive magnetic peripheral nerve stimulation device for painful diabetic neuropathy. Clinical studies—including the SEAT randomized controlled trial—demonstrate a responder rate of up to 65.2% at six months with an average of a 55% reduction in pain scores. Real-world data from VA clinics show a responder rate of up to 78% (>50% pain relief) over more than six months, supporting both efficacy and durability of effect. The company continues to expand clinical research into additional forms of chronic neuropathic pain.
- Therapeutic areas
- Neurology
- Modalities
- DeviceNon-pharmacological therapyMagnetic peripheral nerve stimulation (mPNS)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
None publicly disclosed as major pharma or biotech partnerships.
Beyond the preview
Go deeper on NeuraLace Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuraLace Medical.